Robert Lanza, Chief Scientific Officer at ADVANCED CELL TECHNOLOGY, INC. (ACTC), sold 4,800,000 shares at $0.10 ($460K) on 2010-11-30, disclosed to the SEC on 2010-12-01.
Open-market sale of $460k ACTC by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.08 | 5,000 | $400 | 0.1% |
| 2 | $0.08 | 204,000 | $16K | 3.5% |
| 3 | $0.08 | 385,340 | $31K | 6.7% |
| 4 | $0.08 | 405,660 | $32K | 7.1% |
| 5 | $0.10 | 3,800,000 | $380K | 82.6% |
| Total | $0.10 avg | 4,800,000 |
| $460K |
| 100% |
| Filing → |
| ACTC | SELL | 2012-12-18 | $80K | — | Filing → |
| ACTC | SELL | 2012-08-01 | $160K | — | Filing → |
| ACTC | SELL | 2012-01-25 | $1.4M | — | Filing → |